Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT

ABBOTT has one hundred and eleven approved drugs.

Summary for Abbott

US Patents:	0
Tradenames:	89
Ingredients:	62
NDAs:	111
Patent Litigation for Abbott:	See patent lawsuits for Abbott

Drugs and US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride	INJECTABLE;INJECTION	019714-004	Sep 12, 1988		DISCN	No	No
Abbott	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	089362-001	May 25, 1988		DISCN	No	No
Abbott	AMIKACIN SULFATE	amikacin sulfate	INJECTABLE;INJECTION	063265-001	Nov 30, 1994		DISCN	No	No
Abbott	A-HYDROCORT	hydrocortisone sodium succinate	INJECTABLE;INJECTION	089577-001	Apr 11, 1989		DISCN	No	No
Abbott	GENTAMICIN SULFATE	gentamicin sulfate	INJECTABLE;INJECTION	062413-009	Aug 11, 1983		DISCN	No	No
Abbott	AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019713-004	Sep 9, 1988		DISCN	No	No
Abbott	TPN ELECTROLYTES IN PLASTIC CONTAINER	calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride	INJECTABLE;INJECTION	019399-001	Jun 16, 1986		DISCN	No	No

Expired US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-002	Dec 14, 1994	5,504,207
Abbott	PROSOM	estazolam	TABLET;ORAL	019080-002	Dec 26, 1990	3,987,052
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-001	Aug 7, 1987	5,294,615
Abbott	THYPINONE	protirelin	INJECTABLE;INJECTION	017638-001	Approved Prior to Jan 1, 1982	3,746,697
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994	5,294,615
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-001	Dec 14, 1994	5,412,095
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-002	Dec 14, 1994	5,294,615

Paragraph IV (Patent) Challenges for ABBOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	100 mg		2010-12-21
	Capsules	10 mg and 15 mg		2009-08-14
	Capsules	100 mg		2012-10-31

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Abbott
• Abbott Labs